Cardinal Health understands the distribution needs of clinical labs and provides flexibility, reliability, and visibility for your laboratory.
Assay portability simplifies and standardizes instrument setup within your lab and between labs. It also enables the sharing and exchange of data, ideas and user-defined protocols within and between institutions. Highly reproducible results between instruments drive standardization BD FACSLyric™ System V...
Moreover, the ability of standalone labs to handle large volumes of diagnostic tests at an expedited rate and provide better results at comparatively lower prices is anticipated to offer economies of scale to service providers. There has been an increasing growth of standalone market since the ...
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion) (Numbers of Tests Conducted) 6.7.5. South Korea 6.7.5.1. Key country dynamics 6.7.5.2. Regulatory framework/ reimbursement structure 6.7.5.3. Competitive scenario 6.7.5.4. South Korea market estimates and forecasts 2018...
allowing Medlab to save the cost of domestic and international flights and as a result reducing its carbon footprint.Pre-COVID the team had been travelling internationally six or seven times to present at conferences and join projects, plus the few dozen trips between labs in Australia each ...
For instance, in October 2023, BioAge Labs planned to launch a Phase II clinical trial of azelaprag (BGE-105) with tirzepatide for the treatment of obesity. The company's trial was expected to commence in mid-2024. Thus, such initiatives are projected to support regional market growth. ...
Clinical labs require the ability to consistently recover high-quality nucleic acids, cells and proteins for sensitive downstream applications with maximum reproducibility. The Apex Dx system is designed to be a part of a streamlined modular workflow providing precise result...
In June 2022, AION Labs, in partnership with BioMed X, launched the Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations. AION Labs' fourth start-up will focus on the development of an AI platform that optimizes the patient population for clinic...
North America U.S. Canada Europe Germany UK France Italy Spain Sweden Denmark Norway Asia Pacific China Japan India South Korea Australia Thailand Latin America Brazil Mexico Argentina Middle East and Africa (MEA) Kuwait UAE South Africa Saudi Arabia...
as well as hospital ethics committee (EC) and, in some cases, regional EC approvals before initiating the study. Canada, Australia, and Japan are examples of other countries that all have well-defined regulatory pathways to gain clinical trial approvals for high-risk, life-sustaining devices, ...